<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-96154</identifier>
<setSpec>0004-0614</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Diagnostic performance of malignant prostatic cells detection in blood for early detection of prostate cancer: comparison to prostatic biopsy</dc:title>
<dc:description xml:lang="en">RESULTS: 228 men participated, with a mean age of 66.8 ± 8.8 years and a median serum PSA of 5.15ng/ml. 28.6% of the biopsies were positive for PC, and mCPC were detected in 31.0% of all cases. Sensibility, specifici-ty and negative predictive value were 86.2%, 90.8% and 94.3% respectively. The negative and positive like-lihood ratios were 9.36 and 0.15. In men with a PSA &lt;4.0ngml, 13.3% had cancer detected on biopsy, with a sensibility and specificity for mCPC detection of 83.3% and 84.6% and negative predictive value of 97.1%. All the mCPC determinations were interpretable. There were 9 false negative cases, all with small low grade tumors.CONCLUSIONS: The use of mCPC detection could be useful as a complementary prostate cancer screening test, especially for excluding cancer, including patients with a serum PSA &lt;4.0ng/ml(AU)</dc:description>
<dc:creator>Orellana, N</dc:creator>
<dc:creator>Tapia, P</dc:creator>
<dc:creator>Badinez, L</dc:creator>
<dc:creator>Dueñas, R</dc:creator>
<dc:creator>Reyes, E</dc:creator>
<dc:creator>Murray, Nigel P</dc:creator>
<dc:creator>Fuentealba, C</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">CONCLUSIÓN: La detección de CPCm podría ser útil como examen complementario en la detección de cáncer prostático, en especial para su exclusión, incluido pacientes con PSA &lt; de 4 ng/ml(AU)</dc:description>
<dc:source>Arch Esp Urol;64(10): 961-971, dic. 2011. ilus, tab</dc:source>
<dc:identifier>ibc-96154</dc:identifier>
<dc:title xml:lang="es">Rendimiento diagnóstico de la detección de células prostáticas malignas en la circulación sanguínea para la detección précoz del cáncer prostático: una comparación con la biopsia prostática</dc:title>
<dc:subject>^d29611</dc:subject>
<dc:subject>^d9553^s22071</dc:subject>
<dc:subject>^d11911^s22074</dc:subject>
<dc:subject>^d11914^s22053</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d53221^s22045</dc:subject>
<dc:subject>^d30596^s22002</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d51215^s22074</dc:subject>
<dc:type>article</dc:type>
<dc:date>201112</dc:date>
</metadata>
</record>
</ibecs-document>
